Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort.

Corrado Pedrazzani, Giulia Turri, Daniele Marrelli, Hye Jin Kim, Eun Jung Park, Gaya Spolverato, Caterina Foppa, Antonino Spinelli, Salvatore Pucciarelli, Seung Hyuk Baik, Gyu Seog Choi
Author Information
  1. Corrado Pedrazzani: Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Verona University Hospital, University of Verona, Verona, Italy. corrado.pedrazzani@univr.it.
  2. Giulia Turri: Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Verona University Hospital, University of Verona, Verona, Italy.
  3. Daniele Marrelli: Department of Surgery, Policlinico le Scotte, University of Siena, Siena, Italy.
  4. Hye Jin Kim: Colorectal Cancer Centre, Kyungpook National University Medical Centre, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  5. Eun Jung Park: Division of Colon and Rectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  6. Gaya Spolverato: General Surgery 3, Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.
  7. Caterina Foppa: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  8. Antonino Spinelli: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  9. Salvatore Pucciarelli: General Surgery 3, Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.
  10. Seung Hyuk Baik: Division of Colon and Rectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  11. Gyu Seog Choi: Colorectal Cancer Centre, Kyungpook National University Medical Centre, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

Abstract

BACKGROUND: Since novel strategies for prevention and treatment of metachronous peritoneal metastases (mPM) are under study, it appears crucial to identify their risk factors. Our aim is to establish the incidence of mPM after surgery for colon cancer (CC) and to build a statistical model to predict the risk of recurrence.
PATIENTS AND METHODS: Retrospective analysis of consecutive pT3-4 CC operated at five referral centers (2014-2018). Patients who developed mPM were compared with patients who were PM-free at follow-up. A scoring system was built on the basis of a logistic regression model.
RESULTS: Of the 1423 included patients, 74 (5.2%) developed mPM. Patients in the PM group presented higher preoperative carcinoembryonic antigen (CEA) [median (IQR): 4.5 (2.5-13.0) vs. 2.7 (1.5-5.9), P = 0.001] and CA 19-9 [median (IQR): 17.7 (12.0-37.0) vs. 10.8 (5.0-21.0), P = 0.001], advanced disease (pT4a 42.6% vs. 13.5%; pT4b 16.2% vs. 3.2%; P < 0.001), and negative pathological characteristics. Multivariate logistic regression identified CA 19-9, pT stage, pN stage, extent of lymphadenectomy, and lymphovascular invasion as significant predictors, and individual risk scores were calculated for each patient. The risk of recurrence increased remarkably with score values, and the model demonstrated a high negative predictive value (98.8%) and accuracy (83.9%) for scores below five.
CONCLUSIONS: Besides confirming incidence and risk factors for mPM, our study developed a useful clinical tool for prediction of mPM risk. After external validation, this scoring system may guide personalized decision-making for patients with locally advanced CC.

References

  1. Lancet Oncol. 2020 Sep;21(9):1147-1154 [PMID: 32717180]
  2. Int Semin Surg Oncol. 2005 Feb 08;2(1):3 [PMID: 15701175]
  3. JAMA Surg. 2015 Sep;150(9):890-8 [PMID: 26132363]
  4. Colorectal Dis. 2021 Nov;23(11):2846-2858 [PMID: 34411399]
  5. J Clin Oncol. 2021 Mar 10;39(8):911-919 [PMID: 33439688]
  6. Int J Colorectal Dis. 2015 Feb;30(2):205-12 [PMID: 25503801]
  7. World J Gastroenterol. 2019 Jul 21;25(27):3484-3502 [PMID: 31367152]
  8. Ann Surg. 2005 Feb;241(2):247-55 [PMID: 15650634]
  9. BJS Open. 2020 Apr;4(2):284-292 [PMID: 32207578]
  10. Ann Surg Oncol. 2017 May;24(5):1269-1280 [PMID: 27995451]
  11. Clin Colon Rectal Surg. 2015 Dec;28(4):234-46 [PMID: 26648794]
  12. Lancet Oncol. 2016 Dec;17(12):1709-1719 [PMID: 27743922]
  13. BMC Cancer. 2018 Feb 13;18(1):183 [PMID: 29439668]
  14. Dis Colon Rectum. 2019 Jun;62(6):684-693 [PMID: 30839315]
  15. J Surg Oncol. 2010 Nov 1;102(6):565-70 [PMID: 20976729]
  16. Lancet Oncol. 2021 Feb;22(2):256-266 [PMID: 33476595]
  17. Clin Colon Rectal Surg. 2020 Sep;33(5):253-257 [PMID: 32968360]
  18. Ann Surg Oncol. 2020 Dec;27(13):4943-4948 [PMID: 32535867]
  19. Colorectal Dis. 2021 Mar;23(3):680-688 [PMID: 33124132]
  20. Eur J Surg Oncol. 2014 Aug;40(8):963-9 [PMID: 24183168]
  21. Ann Surg Oncol. 2018 Jan;25(1):212-220 [PMID: 29076043]
  22. Clin Colorectal Cancer. 2018 Sep;17(3):e513-e518 [PMID: 29661621]
  23. Oncologist. 2020 Dec;25(12):e1968-e1979 [PMID: 32926498]
  24. Eur J Surg Oncol. 2020 Dec;46(12):2283-2291 [PMID: 32873455]
  25. J Chronic Dis. 1987;40(5):373-83 [PMID: 3558716]
  26. Br J Surg. 2012 May;99(5):699-705 [PMID: 22287157]
  27. Colorectal Dis. 2014 May;16(5):359-67 [PMID: 24410859]
  28. J Surg Oncol. 2021 Feb;123(2):622-629 [PMID: 33616972]
  29. Colorectal Dis. 2017 Mar;19(3):224-236 [PMID: 28008728]
  30. World J Surg Oncol. 2021 Apr 15;19(1):120 [PMID: 33858443]
  31. Int J Surg. 2017 Oct;46:198-202 [PMID: 28890409]
  32. Ann Surg. 2004 Aug;240(2):205-13 [PMID: 15273542]
  33. J Clin Oncol. 2011 Aug 10;29(23):3163-72 [PMID: 21747092]
  34. Acta Oncol. 2015 Jan;54(1):5-16 [PMID: 25430983]
  35. Colorectal Dis. 2020 Dec;22(12):2123-2132 [PMID: 32940414]
  36. Clin Colon Rectal Surg. 2005 Aug;18(3):182-9 [PMID: 20011301]
  37. Lancet Gastroenterol Hepatol. 2019 Oct;4(10):761-770 [PMID: 31371228]
  38. Dis Colon Rectum. 2018 Jul;61(7):803-808 [PMID: 29561282]
  39. Br J Surg. 2002 Dec;89(12):1545-50 [PMID: 12445064]
  40. Ann Surg. 2011 Aug;254(2):289-93 [PMID: 21709543]
  41. Ann Surg Oncol. 2013 Jan;20(1):183-92 [PMID: 23090572]
  42. Lancet Oncol. 2020 Sep;21(9):1124-1125 [PMID: 32717181]
  43. Gastric Cancer. 2022 May;25(3):629-639 [PMID: 34811622]
  44. BMC Cancer. 2015 May 24;15:428 [PMID: 26003804]
  45. Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Dec 25;22(12):1115-1117 [PMID: 31874525]
  46. Colorectal Dis. 2016 Apr;18(4):378-85 [PMID: 26588669]

MeSH Term

Carcinoembryonic Antigen
Colonic Neoplasms
Humans
Neoplasm Staging
Peritoneal Neoplasms
Prognosis
Retrospective Studies

Chemicals

Carcinoembryonic Antigen

Word Cloud

Created with Highcharts 10.0.0mPMrisk0vsCCmodeldevelopedpatients52%PstudyfactorsincidencerecurrencefivePatientsscoringsystemlogisticregression[medianIQR:27=001]CA19-9advancednegativestagescoresBACKGROUND:SincenovelstrategiespreventiontreatmentmetachronousperitonealmetastasesappearscrucialidentifyaimestablishsurgerycoloncancerbuildstatisticalpredictPATIENTSANDMETHODS:RetrospectiveanalysisconsecutivepT3-4operatedreferralcenters2014-2018comparedPM-freefollow-upbuiltbasisRESULTS:1423included74PMgrouppresentedhigherpreoperativecarcinoembryonicantigenCEA45-1315-5917120-371080-21diseasepT4a426%135%pT4b163<001pathologicalcharacteristicsMultivariateidentifiedpTpNextentlymphadenectomylymphovascularinvasionsignificantpredictorsindividualcalculatedpatientincreasedremarkablyscorevaluesdemonstratedhighpredictivevalue988%accuracy839%CONCLUSIONS:Besidesconfirmingusefulclinicaltoolpredictionexternalvalidationmayguidepersonalizeddecision-makinglocallyPredictionMetachronousPeritonealMetastasesRadicalSurgeryColonCancer:ScoringSystemObtainedInternationalMulticenterCohort

Similar Articles

Cited By